Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Antonie Van Leeuwenhoek|August 7, 2008
Molecular characterization of methicillin-resistant Staphylococcus aureus nasal isolates from TurkeyAbdullah Kilic, Gurkan Mert, Zeynep Senses, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2006
Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agentsKlaudia Kosowska-Shick, Kim L Credito, Glenn A Pankuch, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2009
Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studiesKlaudia Kosowska-Shick, Catherine Clark, Glenn A Pankuch, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2009
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanismsPamela McGhee, Catherine Clark, Klaudia M Kosowska-Shick, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2008
Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical CenterKlaudia Kosowska-Shick, Lois M Ednie, Pamela McGhee, et al.
Diagnostic Microbiology and Infectious Disease|May 12, 2004
In vitro selection of resistance in haemophilus influenzae by 4 quinolones and 5 beta-lactamsCatherine Clark, Klaudia Kosowska, Bülent Bozdogan, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
Activities of a new oral streptogramin, XRP 2868, compared to those of other agents against Streptococcus pneumoniae and haemophilus speciesGlenn A Pankuch, Linda M Kelly, Gengrong Lin, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2002
Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutationsBrigitte Malbruny, Kensuke Nagai, Maëlle Coquemont, et al.
Pageof 14